RxDoctor Payments Data

Laura Ostezan

Dermatology · Reno, NVNPI 1356455851

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $24,000 of the $27,176 with a category attached, or 88.3%. AbbVie accounts for 94.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $9,942 and has fallen 97.3% since, to $267 in 2025. Among dermatology clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,176in general payments, 2019–2025

Across 158 payments — averaging $172.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$26K
  • Johnson & Johnson$202
  • Lilly USA, LLC$164
  • Amgen$163
  • Sun Pharmaceutical Industries Inc.$122
  • Merz North America, Inc.$113
  • plus $805 from 14 others

What the payments were for

  • Speaking & faculty fees$24,00088%
  • Travel & lodging$1280%
  • Food & beverage$3,04811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,176 in reported general payments places this provider in the 90th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Other dermatology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →